Clinical consequences of muscle dysfunction in chronic obstructive pulmonary disease;Consecuencias clínicas de la disfunción muscular en la enfermedad pulmonar obstructiva crónica

Nutricion Hospitalaria

Volumn 21, Issue SUPPL. 3, 2006, Pages 69-75

  Roig, J Sauleda ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

COPD; Diaphragm; Dynamic hyperinflation; Exercise; Muscle fatigue; Peripheral muscle; Quadriceps; Rehabilitation; Respiratory muscles; Under nutrition

Indexed keywords

ARTIFICIAL VENTILATION; BREATHING MUSCLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; ELECTROMYOGRAPHY; HUMAN; HYPERINFLATION; HYPOVENTILATION; LUNG FUNCTION; LUNG VOLUME; MUSCLE DISEASE; MUSCLE FATIGUE; MUSCLE STRENGTH; RESPIRATORY FAILURE; REVIEW; SPIROMETRY;

HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES;

EID: 33745109247     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Celli BR, MacNee W, Agusti AG y cols.: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
2. Marchand E, Decramer M: Respiratory muscle function and drive in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21(4):679-692.
3. Sinderby C, Spahija J, Beck J, Kaminski D, Yan S, Comtois N, Sliwinski P: Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(7):1637-1641.
4. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F: Peripheral muscle weakness in patient with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:629-634.
5. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21(2):347-360.
6. Sauleda J, Maimo A: Musculos respiratorios; in: Agusti AGN, (ed): 1994. pp. 25-30.
7. Polkey MI, Kyroussis D, Hamengard C-H, Mills GH, Green M, Moxham J: Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:1310-1317.
8. Grassino A, Clanton T: Respiratory muscle fatigue. Sem Respir Med 1991; 12:305-321.
9. Ninane V: "Intrinsic" PEEP(PEEPi): role of expiratory muscles. Eur Respir J 1997; 10:516-518.
10. Polkey MI, Green M, Moxham J: Measurament of respiratory muscle stregnth. Thorax 1995; 50:1131-1135.
11. Gray BA, Blalock JM: Interpretation of the A-a O2 difference in patients with hypercapnia. Am Rev Respir Dis 1991; 143:4-8.
12. NHLBI Workshop Summary: Respiratory muscle fatigue: report of the respiratory muscle fatigue workshop group. Am Rev Respir Dis 1990; 142:474-480.
13. Gea J, Sauleda J, Orozco-Levi M, Aguar MC, Barreiro E, Broquetas JM: Función diafragmática durante el ejercicio en pacientes con EPOC severa. Arch Bronconeumol 1999; 35(6):280-286.
14. Martyn JB, Moreno RH, Paré PD, Pardy RL: Measurement of inspiratory muscle performance with incremental threshold loading. Am Rev Respir Dis 1987; 135:919-923.
15. Rochester DF: Tests of respiratory muscle function. Clin Chest Med 1988; 9:241-261.
16. Nici L: Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21(4):693-704.
17. Bauerle O, Chrusch CA, Younes M: Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998; 157(1):57-68.
18. Marin JM, Hussain SN, Gibbons WJ, Polverino M, Levy RD, Cosio MG: Relationship of resting lung mechanics and exercise pattern of breathing in patients with chronic obstructive lung disease. Chest 1993; 104(3):705-711.
19. Montes de OM, Celli BR: Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161(3 Pt 1):880-885.
20. Nava S, Fuccella LM, Viglianti B: Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD. Monaldi Arch Chest Dis 2004; 61(4):203-208.
21. Palange P, Forte S, Felli A, Carlone S: Nutritional status and exercise perfomance in chronic obstructive pulmonary disease (COPD). Monaldi Arch Chest Dis 1993; 48:543-545.
22. Grazzini M, Stendardi L, Rosi E, Scano G: Pharmacological treatment of exercise dyspnoea. Monaldi Arch Chest Dis 2001; 56(1):43-47.
23. Martínez FJ, Montes de Oca M, Whte RI, Stetz J, Gay SE, Celli BR: Lung-volume reduction improves dyspnea, dynamic hyperinflation,and respiratory muscle function. Am J Respir Crit Care Med 1997; 155:1984-1990.
24. Beckerman M, Magadle R, Weiner M, Weiner P: The effects of 1 year of specific inspiratory muscle training in patients with COPD. Chest 2005; 128(5):3177-3182.
25. Nava S, Ambrosino N, Bruschi C, Confalonieri M, Rampulla C: Physiological effects of flow and pressure triggering during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease. Thorax 1997; 52(3):249-254.
26. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F: Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30(10):1467-1474.
27. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F: Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30(10):1467-1474.
28. Sauleda J, García-Palmer FJ, Wiesner R, Tarraga S, Harting I, Tomás P, Gómez C, Saus C, Palou A, Agustí AGN: Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(5):1413-1417.
29. Maltais F, Leblanc P, Jobin J, Casaburi R: Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21(4):665-677.
30. Killian KJ: Limitation to muscular activity in chronic obstructive pulmonary disease. Eur Respir J 2004; 24(1):6-7.
31. Wang XN, Williams TJ, McKennna MJ, Li JL, Fraser SF, Side EA, Snell GI, Walters EH, Carey MF: Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. Am J Respir Crit Care Med 1999; 160:57-63.
32. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, González de Suso JM, Vilaro J, Barberá JA, Polo MF, Argilés JM, Fernández-Checa JC, Roca J: Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164(7):1114-1118.
33. Maltais F, Simard AA, Simard C, Jobin J, Desgagnés P, Leblanc P, Janvier R: Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288-293.
34. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K: Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143:9-18.
35. Hernández N, Orozco-Levi M, Belalcázar V, Pasto M, Minguella J, Broquetas JM, Gea J: Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 2003; 134(3):219-229.
36. Simpson K, Killian K, McCartney N, Stubbing DG, Jones NL: Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992; 47(2):70-75.
37. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G: Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10(2):417-423.
38. Schols AM, Slangen J, Volovics L, Wouters EF: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(6 Pt 1):1791-1797.
39. Celli BR, Cote CG, Marín JM, Casanova C, Montes de OM, Méndez RA, Pinto P, V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005-1012.
40. Baarends EM, Marken Lichtenbelt WD, Wouters EF, Schols AM: Body-water compartments measured by bio-electrical impedance spectroscopy in patients with chronic obstructive pulmonary disease. Clin Nutr 1998; 17(1):15-22.
41. Engelen MP, Schols AM, Does JD, Wouters EF: Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 71(3):733-738.
42. Dubowitz V, Brooke MH: The procedure of muscle biopsy; in: Dubowitz V, Brooke MH, (eds): Muscle biopsy: a modern approach. London, Philadelphia, W.B. Saunders Company, 1973, pp 5-19.
43. Maltais F, Leblanc P, Whittom F, Simard C, Marquis K, Belanger M, Breton MJ, Jobin J: Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000; 55(10):848-853.
44. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D: Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999; 160(4):1248-1253.
45. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS: Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348(9035):1115-1119.
46. Troosters T, Casaburi R, Gosselink R, Decramer M: Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2005.
47. Piepoli MF, Davos C, Francis DP, Coats AJ: Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). Brit Med J 2004; 328(7433):189.
48. Das UN: Anti-inflammatory nature of exercise. Nutrition 2004; 20(3):323-326.
49. Ferreira IM, Verreschi IT, Nery LE, Goldstein RS, Zamel N, Brooks D, Jardim JR: The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998; 114(1):19-28.
50. Mannix ET, Boska MD, Galassetti P, Burton G, Manfredi F, Farber MO: Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS. J Appl Physiol 1995; 78(6):2218-2227.